N
NeuMoDx Molecular
Solutions for molecular diagnostic (mdx) testing
About NeuMoDx Molecular
Neumodx is a cutting-edge startup specializing in automated molecular diagnostic systems. Their primary focus is on creating scalable platforms that streamline the entire molecular diagnostic process, from sample collection to final results. These systems are designed to serve modern clinical laboratories, offering solutions that are both efficient and flexible.
Neumodx's product lineup includes various test strips and assays, such as the HPV Test Strip and the SARS-CoV-2 Assay. These products are crucial for detecting specific pathogens and diseases, making them highly relevant in today's healthcare landscape. The company also offers proprietary reagents and consumables that are stable at room temperature, reducing waste and enhancing operational efficiency.
One of the standout features of Neumodx's systems is their "continuous random access" capability. This means that samples and testing consumables can be loaded at any time, allowing for up to 8 hours of unattended operation. This feature is particularly beneficial for clinical labs that require high throughput and minimal downtime. The systems are also scalable, meaning they can be adjusted to meet the varying needs of different laboratories, whether they require the 96 or 288 Molecular System.
Neumodx operates in the molecular diagnostics market, which is a rapidly growing sector within the broader healthcare industry. Their business model revolves around selling their diagnostic platforms and the associated consumables. By providing a comprehensive solution that integrates sample handling, liquid transport, and diagnostic testing, Neumodx ensures a steady revenue stream from both the initial sale of their systems and the ongoing sale of consumables.
In summary, Neumodx is revolutionizing the molecular diagnostics field with their fully automated, scalable platforms that offer continuous random access and high operational efficiency. Their products are designed to meet the needs of modern clinical laboratories, making molecular diagnostics simpler and more effective.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2012
- Headquarters
- Ann Arbor, United States
- Employees
- 20
- Open positions
- None listed
- Dealroom signal
- 26.0/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Testing, Biotechnology, Biotech and Pharma, Hard Tech, medical testing, DT and LS, science-based
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Sep 2020 | $248M | — | Qiagen | — |
| LATE VCOther financing | May 2018 | $20M | $80M | Undisclosed | — |
Growth signals
Latest recorded traffic for NeuMoDx Molecular is 1.2K monthly website visits, up 71.4% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Wolverine Venture Fund
Venture Investors Health Fund
Robert W. Baird & Co.
Baird Capital
Arboretum Ventures
Series B and later1 investor entered at this stage
- PVPfizer Ventures
Other known investors1 additional known investor
Qiagen
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about NeuMoDx Molecular on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See NeuMoDx Molecular’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







